These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1770 related items for PubMed ID: 18356555
1. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [Abstract] [Full Text] [Related]
2. Is visceral obesity the cause of the metabolic syndrome? Després JP. Ann Med; 2006 Jun; 38(1):52-63. PubMed ID: 16448989 [Abstract] [Full Text] [Related]
3. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Després JP, Cartier A, Côté M, Arsenault BJ. Ann Med; 2008 Jun; 40(7):514-23. PubMed ID: 18608131 [Abstract] [Full Text] [Related]
4. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. Wisse BE. J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932 [Abstract] [Full Text] [Related]
5. [Relationship of different types of abdominal obesity to risk of metabolic syndrome]. He HB, Zhao ZG, Pu YF, Chen J, Ni YX, Zhong J, Liu HY, Li YS, Yan ZC, Liu DY, Zhu ZM. Zhonghua Yi Xue Za Zhi; 2008 May 13; 88(18):1251-4. PubMed ID: 18844097 [Abstract] [Full Text] [Related]
6. Abdominal obesity and metabolic syndrome. Després JP, Lemieux I. Nature; 2006 Dec 14; 444(7121):881-7. PubMed ID: 17167477 [Abstract] [Full Text] [Related]
7. Waist circumference measurement in clinical practice. Ness-Abramof R, Apovian CM. Nutr Clin Pract; 2008 Dec 14; 23(4):397-404. PubMed ID: 18682591 [Abstract] [Full Text] [Related]
8. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Blackburn P, Lemieux I, Alméras N, Bergeron J, Côté M, Tremblay A, Lamarche B, Després JP. Metabolism; 2009 Aug 14; 58(8):1123-30. PubMed ID: 19481769 [Abstract] [Full Text] [Related]
9. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. BJOG; 2006 Oct 14; 113(10):1203-9. PubMed ID: 16753044 [Abstract] [Full Text] [Related]
10. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. Després JP. J Endocrinol Invest; 2006 Oct 14; 29(3 Suppl):77-82. PubMed ID: 16751711 [Abstract] [Full Text] [Related]
11. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Haffner SM. Am J Med; 2007 Sep 14; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354 [Abstract] [Full Text] [Related]
13. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Misra A, Khurana L. Metab Syndr Relat Disord; 2009 Dec 14; 7(6):497-514. PubMed ID: 19900153 [Abstract] [Full Text] [Related]
16. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Lee K, Lee S, Kim YJ, Kim YJ. Nutrition; 2008 Dec 14; 24(7-8):625-31. PubMed ID: 18485667 [Abstract] [Full Text] [Related]
17. The metabolic syndrome - an ongoing story. Duvnjak L, Duvnjak M. J Physiol Pharmacol; 2009 Dec 14; 60 Suppl 7():19-24. PubMed ID: 20388942 [Abstract] [Full Text] [Related]